| Peri-operative cardiac output-guided, haemodynamic therapy algorithm | Usual care |
---|---|---|
(n = 368) | (n = 365) | |
Surgery | Â | Â |
 Upper gastrointestinal | 108 (29.4) | 111 (30.4) |
 Lower gastrointestinal | 168 (45.7) | 165 (45.2) |
 Small bowel +/− pancreas | 86 (23.4) | 82 (22.5) |
 Urological or gynaecological involving gut | 5 (1.4) | 4 (1.1) |
 No surgery performed | 1 (0.3) | 3 (0.8) |
Intervention | Â | Â |
 Cardiac monitor used | 364 (98.9) | 31 (8.5) |
 Dopexamine dose infused (mg) | 18.9 (8.4) | – |
 Intra-venous crystalloid (ml) |  |  |
  During surgery | 1518 (1410) | 2420 (1382) |
  6 h following surgery | 565 (254) | 670 (367) |
 Intra-venous colloid (ml) |  |  |
  During surgery | 1465 (913) | 708 (695) |
  6 h following surgery | 642 (498) | 226 (361) |
 Blood products (ml) |  |  |
  During surgery | 141 (723) | 95 (542) |
  6 h following surgery | 80 (555) | 10 (66) |
Length of stay (days) | Â | Â |
 Critical care level 2 | 2.5 (3.7) | 2.6 (3.4) |
 Critical care level 3 | 0.7 (2.4) | 0.9 (3.8) |
 General surgical ward | 10.3 (14.4) | 11.4 (12.6) |